Renal tumouroids: challenges of manufacturing 3D cultures from patient derived primary cells

Recent advancements in 3D in vitro culture have allowed for the development of cancer tissue models which accurately recapitulate the tumour microenvironment. Consequently, there has been increased innovation in therapeutic drug screening. While organoid cultures show great potential, they are limited by the time scale of their growth in vitro and the dependence upon commercial matrices, such as Matrigel, which do not allow for manipulations of their composition or mechanical properties. Here, we show a straightforward approach for the isolation and culture of primary human renal carcinoma cells and matched non‐affected kidney. This approach does not require any specific selection for cancer cells, and allows for their direct culture in amenable 3D collagen‐based matrices, with the preservation of cancer cells as confirmed by NGS sequencing. This method allows for culture of patient‐derived cancer cells in 3D microenvironment, which can be used for downstream experimentation such as investigation of cell–matrix interaction or drug screening.